Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
ANNX similar filings
- 3 Nov 22 Annexon Reports Third Quarter 2022 Financial Results and Plans to Provide Updates on Complement Therapeutic Portfolio in January 2023
- 8 Aug 22 Annexon Biosciences Highlights Business and Portfolio Progress and Key Anticipated Milestones and Reports Second Quarter 2022 Financial Results
- 8 Jul 22 Annexon Announces $130 Million Private Placement Financing
- 10 Jun 22 Submission of Matters to a Vote of Security Holders
- 7 Jun 22 Other Events
- 9 May 22 Annexon Biosciences Highlights Portfolio Progress and Key Anticipated Milestones, and Reports First Quarter 2022 Financial Results
- 7 Apr 22 Annexon Biosciences Completes Enrollment in ARCHER Phase 2 Trial of Novel C1q Inhibitor, ANX007, in Patients with Geographic Atrophy
Filing view
External links